Clinical trial: Modified-release prednisone for RA
This is a study to compare the safety and effectiveness of a combination of Lodotra (modified-release prednisone) and standard disease-modifying anti-rheumatic drugs (DMARDs) to a combination of a placebo and DMARDs in patients with active rheumatoid arthritis. This international study is currently recruiting patients.
Read full story >
See all Rheumatoid Arthritis News













